More Company News

Scancell

Encouraging early efficacy data from ModiFY trial
21 Feb 2023Read More

Scancell

Positive response in COVIDITY trial
13 Feb 2023Read More

Scancell

Dr Jean-Michel Cosséry appointed Chairman
01 Feb 2023Read More

Scancell

H123 interim results
25 Jan 2023Read More

Scancell

Vaccitech technology licenced to advance Modi-2
07 Nov 2022Read More

Scancell

First patient dosed in expansion phase of ModiFY
31 Oct 2022Read More

Scancell

FY22 results for year ended 30 April 2022
28 Oct 2022Read More

Scancell

Directorate changes
26 Oct 2022Read More

Scancell

Commercial licence agreement with Genmab
25 Oct 2022Read More

Scancell

Change of NOMAD
13 Oct 2022Read More

1 2 3 4 … 8
Return to Scancell
© 2019-22 Trinity Delta. All rights reserved. Trinity Delta is regulated by the Financial Conduct Authority (Reference number: 725161).